To further validate the effect of NEK2 on ccRCC, we performed subcutaneous tumorigenesis in nude mice by applying the constructed 786-O cells with stable interference of NEK2 and the negative control cells to observe the tumor cell growth in vivo. This evidence concerns the gene NEK2 and nonpapillary renal cell carcinoma.